Since the early 90s, Ceit has been working in the field of micro and nanotechnologies. With the rise of Biomedical Engineering in recent years, the knowledge acquired has been applied to the development of devices for monitoring biological events of direct application in the field of health or in the food sector.
In this way, a multitude of technological solutions have been developed based on concepts such as bioMEMS, Lab-on-a-chip systems (LOC), or micro Total Analysis systems (µTAS). These developments have allowed us to develop the latest technology in the detection of immunological, genomic, enzymatic reactions, etc.
This technology offers significant advantages such as miniaturization, rapid response, easy integration, and ease of portability and scalability to the industry. It is especially interesting when applied in industrial settings, commercial devices, healthcare settings, food industries, etc. Specifically, the healthcare market is requiring increasingly autonomous and reliable methods for analysis systems (Point of Care).
The combination of these developments with the development of microfluidic platforms in which small sample volumes can be managed has allowed the generation of a line of research in the field of personalized medicine and drug testing.